Top 10 stocks that made news today: Amtek Auto, Unitech, BHEL and more

Amtek Auto Shares ended 5.63 per cent down at Rs 27.65 after the company reported net loss of Rs 132.15 crore for the quarter ended December 31, 2015 as compared to net profit of Rs 70.81 crore for the same quarter in the pre

Stocks that made news today

US FDA observations for Shendra facility not critical: Wockhardt

According to the company, half of the issues will be resolved in next fortnight The nine observations received by Wockhardt for its Shendra facility in Aurangabad from the US health regulator are not ‘critical’ in

USFDA observations for Shendra facility not critical: Wockhardt

The facility, which produces various products including ointments, capsules and tablets, currently caters to the UK and Ireland markets.


USFDA makes 9 observations over Wockhardt’s plant in Aurangabad

The USFDA has made nine 'observations' highlighting violations of its norms at homegrown drug maker Wockhardt's new facility at Shendra in Aurangabad.


Wockhardt falls more than 10% on reports over US FDA notice

Wockhardt shares fell as much as 12.69 per cent intraday on Friday on reports the company has received a notice from the US Food and Drug Administration

aurobindo pharma, bse sensex

Wockhardt receives QIDP status from US FDA

WCK 5222 is a new class of antibiotic for gram negative terrain for complicated urinary tract infections and HABP/ VABP Wockhardt announced that US Food and Drug Administration (US FDA) has granted WCK 5222, a product from th

Wockhardt gets QIDP status for new antibiotic product from FDA

Drug maker Wockhardt has received qualified disease product (QIDP) status from US health regulator for a new antibiotic.


Wockhardt’s Chikalthana plant gets GMP certificate from UKMHRA

The UK regulator had in October 2013 withdrawn the GMP certificate to the Chikalthana plant Wockhardt’s Chikalthana plant at Aurangabad in Maharashtra has received a good manufacturing practice (GMP) certificate from th

Wockhardt gets exemption from price control for three insulin products

The three products have been classified as new drugs and thus qualify for non-application of the DPCO 2013 Drug price regulator National Pharmaceutical Pricing Authority (NPPA) has exempted Wockhardt’s three insulin product

NPPA exempts Wockhardt’s 3 insulin products from price control

Wockhardt had applied to the National Pharmaceutical Pricing Authority (NPPA) for non-application of price control provisions of the DPCO 2013 on the three drugs.


Wockhardt Q2 net zooms to Rs 108 crore

Wockhardt today reported a multi-fold jump in consolidated net profit at Rs 107.59 crore for the second quarter ended September 30, mainly on account of robust sales and lower tax expense.


Wockhardt shares gain after UK MHRA says no critical observations at drug plant

Wockhardt shares were trading over 2 per cent up after the company said that UK's health regulator Medicines and Healthcare Products Regulatory Agency has found "no critical observations" at its L-1 Chikalthana drug manufactu

Wockhardt shares

Why Indian pharma stocks are performing better than their global counterparts

The double-digit stock market gains of Indian pharmaceutical giants including Dr. Reddy's Laboratories and Wockhardt stand out in stark relief to the dismal performance of other Asian emerging-market stocks this year.

Dr Reddy's Lab

Sun Pharma, Wockhardt recall drugs from US market

Sun Pharma’s recall was initiated last month under Class-III classification while Wockhardt’s recall was under class-II classification Sun Pharma and Wockhardt have separately initiated voluntary recall of a number of

Wockhardt’s consolidated revenue for Q1FY16 grows by 15 per cent at Rs1141 crore

EBIDTA is up by 165 per cent at Rs 167 crore Wockhardt has posted its first quarter results for financial year 2016. The company’s turnover during the quarter grew by 15 per cent on strong growth in the UK and India busines

Wockhardt recalls over 50 lakh bottles of various drugs in US

Wockhardt is recalling over 50 lakh bottles of various drugs, used for treating ailments like high blood pressure and ulcer.

Wockhardt shares

Wockhardt recalls over 1.62 lakh cartons of drugs in US

Drug firm Wockhardt is recalling 1,62,142 cartons of various drugs, which are used to treat ailments like high blood pressure and ulcer, in the US market due to deviations in current good manufacturing practice norms laid dow


Wockhardt Q4FY15 net sales posted at Rs1079 crore

International business contributed 72 per cent of the total revenues during the FY14-15

Wockhardt recalls 12 drugs in US made at two India units

Wockhardt has decided to voluntarily recall all the remaining batches of 12-15 products that were manufactured in the Chikalthana and Waluj facilities prior to the import alert imposed by the US Food and Drug Administration (

Wockhardt recalls 12 drugs in US made at 2 India units

Wockhardt said this was a measure of preparedness and abundant precaution and there is no evidence of risk to patient safety from these products that are currently available in the US market

Wockhardt recalls 12 drugs in US made at 2 India units

Wockhardt said this was a measure of preparedness and abundant precaution and there is no evidence of risk to patient safety from these products that are currently available in the US market.

Wockhardt Foundation undertakes community education activities on World Health Day

Educates 1500 people from five slums in Mumbai on‘Clean and Healthy living’ through its Khel Khel Mein pragramme, educates 28500 people across India on ‘food safety and hygiene' through its flagship Mobile1000 programme

We should be able to recover 50-60% sales from Chikalthana: Habil Khorakiwala, Wockhardt

A day after Wockhardt said that the recent USFDA’s follow-up inspection was to assess the progress made in areas of good manufacturing practices remediation...

Outperform on Wockhardt, target of Rs 1,700

Retain ‘outperform’ on Wockhardt (WPL) with a 12-month price target of Rs 1,700.

Wockhardt’s Chikalthana plant to regain the lost ground soon

In 2013, the USFDA had issued an import alert on the company's Aurangabad-based Waluj and Chikalthana facilities

USFDA did not find issues at Wockhardt’s Chikalthana facility

Drugmaker Wockhardt on Wednesday notified the stock exchanges that there were no findings by US FDA with respect to data security and control measures...

Income Tax Calculator, Budget 2019, How to Calculate Income Tax


Stock Market

Most Read


Budget 2020


Related Articles